Ibusolve (Ibuprofen)

Ibuprofen exerts its effect by reversibly inhibiting cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are key in the conversion of arachidonic acid to prostaglandins. By lowering prostaglandin synthesis, it reduces inflammation, pain signaling, and fever generation in the body.

The dosage of Ibusolve is determined by the prescribing healthcare professional based on the individual’s age, weight, condition being treated, and response to therapy. Patients should follow the prescriber’s instructions and the product labeling; no fixed regimen is provided here.

Ibuprofen is generally avoided during the third trimester of pregnancy because it may affect fetal cardiovascular function. Use during earlier stages or while breastfeeding should only be considered if the prescriber determines that the benefits outweigh potential risks, and alternative therapies may be preferred.

To place an order, submit an enquiry on the Ibusolve product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Ibusolve’s active ingredient, ibuprofen, shares the same mechanism of action as other non‑steroidal anti‑inflammatory drugs such as naproxen or diclofenac, offering comparable analgesic and antipyretic effects. Differences may lie in dosing frequency, potency, gastrointestinal tolerability and individual patient response, which the prescriber evaluates when selecting therapy.

Ibusolve should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or temperature fluctuations to maintain its stability.

Ibusolve is intended for oral administration. The tablets (or capsules) should be swallowed whole with a full glass of water, preferably with food or a milk product to reduce potential gastrointestinal irritation. Do not crush, chew, or split the dosage form unless specifically instructed by a healthcare professional.

Serious adverse events, though uncommon, can include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, renal impairment, hepatotoxicity, and increased risk of cardiovascular events like myocardial infarction or stroke. Patients should seek immediate medical attention if they experience symptoms such as black stools, severe abdominal pain, swelling, or breathing difficulties.

Ibusolve should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcer disease, severe renal or hepatic impairment, and in the third trimester of pregnancy. It is also contraindicated in patients receiving certain anticoagulants or other medications that may interact dangerously, unless a prescriber determines that the benefits outweigh the risks.